Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer
Human Pathology Sep 09, 2017
Jang MH, et al. - The objective here was to contemplate the clinicopathologic importance of expression of epithelial-mesenchymal transition (EMT)-related miRNAs, miR-9 and miR-155, in triple-negative breast cancers (TNBCs). The data indicated that the expression levels of both miR-9 and miR-155 could possibly serve as candidates for prognostic biomarkers in TNBCs.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
